<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">10202746</PMID>
      <DateCompleted>
        <Year>1999</Year>
        <Month>07</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2013</Year>
        <Month>11</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0024-7758</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>44</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>1999</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of reproductive medicine</Title>
          <ISOAbbreviation>J Reprod Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Intrauterine devices. The optimal long-term contraceptive method?</ArticleTitle>
        <Pagination>
          <StartPage>269</StartPage>
          <EndPage>274</EndPage>
          <MedlinePgn>269-74</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To review selected data on the effectiveness, safety, cost and technical ease of intrauterine device (IUD) use compared with Norplant and surgical sterilization.</AbstractText>
          <AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Literature review.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">IUDs are highly effective, safe and relatively inexpensive methods of contraception that may offer advantages for some women over other long-term methods, such as sterilization and Norplant. IUDs provide protection against pregnancy comparable to that provided by female sterilization, and they may be more effective than Norplant. IUDs have a long duration of effectiveness: the copper T 380A (TCu380A) is effective for at least 10 years, and the levonorgestrel (LNg) IUD appears to be effective for at least 7. Norplant is effective for only five years. Both types of IUD can disrupt menstrual bleeding patterns, although the patterns of bleeding are different. Copper IUDs often increase blood loss, whereas the LNg IUD, like Norplant, substantially reduces menstrual bleeding. The most important adverse outcome associated with IUD use is higher rates of pelvic inflammatory disease; careful attention to proper insertion techniques can reduce this risk substantially, and LNg IUDs may cause no increase in risk. IUDs, like both sterilization and Norplant, provide no protection against sexually transmitted disease. The TCu380A IUD is extremely cost-effective. There is as yet no public sector price for the LNg IUD, which has not been approved by the U.S. Food and Drug Administration and is not provided by family planning donor organizations. If it can be made available to the public sector at a price substantially less than its present market price, the LNg IUD would be a useful addition to the contraceptive armamentarium for developing countries.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Providers, consumers and family planning program managers should begin to see IUDs as potential substitutes for both surgical sterilization and Norplant.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Fortney</LastName>
            <ForeName>J A</ForeName>
            <Initials>JA</Initials>
            <AffiliationInfo>
              <Affiliation>Family Health International, Research Triangle Park, North Carolina 27709, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Feldblum</LastName>
            <ForeName>P J</ForeName>
            <Initials>PJ</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Raymond</LastName>
            <ForeName>E G</ForeName>
            <Initials>EG</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D003160">Comparative Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Reprod Med</MedlineTA>
        <NlmUniqueID>0173343</NlmUniqueID>
        <ISSNLinking>0024-7758</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D003271">Contraceptive Agents, Female</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>5W7SIA7YZW</RegistryNumber>
          <NameOfSubstance UI="D016912">Levonorgestrel</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>J Reprod Med. 1999 Jul;44(7):656</RefSource>
          <PMID Version="1">10442337</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003271" MajorTopicYN="Y">Contraceptive Agents, Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007434" MajorTopicYN="Y">Intrauterine Devices</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
          <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
          <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007435" MajorTopicYN="N">Intrauterine Devices, Copper</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
          <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
          <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007436" MajorTopicYN="N">Intrauterine Devices, Medicated</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
          <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
          <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016912" MajorTopicYN="Y">Levonorgestrel</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013246" MajorTopicYN="Y">Sterilization, Tubal</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <NumberOfReferences>19</NumberOfReferences>
      <OtherID Source="PIP">146675</OtherID>
      <OtherID Source="POP">00291848</OtherID>
      <OtherAbstract Type="PIP" Language="eng">
        <AbstractText>This study reviews literatures on the effectiveness, safety, cost and technical ease of IUD use as compared with Norplant and surgical sterilization. Findings revealed that IUDs are highly effective, safe and relatively inexpensive methods of contraception that may offer advantages for some women over other long-term methods, such as sterilization and Norplant. IUDs provide protection against pregnancy comparable to that provided by female sterilization, and they may be more effective than Norplant. IUDs have a long duration of effectiveness: the copper T 380A is effective for at least 10 years, and the levonorgestrel (LNG) IUD seems to be effective for at least 7 years. Norplant is effective for only 5 years. Both types of IUD can disturb menstrual bleeding patterns, although the patterns of bleeding are different. Copper IUDs often increase blood loss, whereas the LNG IUD, like Norplant, substantially reduces menstrual bleeding. The most important adverse outcome associated with IUD use is higher rates of pelvic inflammatory disease; careful attention to proper insertion techniques can reduce this risk substantially, and LNG IUDs may cause no increase in risk. IUDs, like both sterilization and Norplant, provide no protection against sexually transmitted diseases.</AbstractText>
      </OtherAbstract>
      <KeywordList Owner="PIP">
        <Keyword MajorTopicYN="N">Americas</Keyword>
        <Keyword MajorTopicYN="N">Contraception</Keyword>
        <Keyword MajorTopicYN="N">Contraceptive Agents</Keyword>
        <Keyword MajorTopicYN="N">Contraceptive Agents, Female</Keyword>
        <Keyword MajorTopicYN="N">Contraceptive Agents, Progestin</Keyword>
        <Keyword MajorTopicYN="Y">Contraceptive Effectiveness</Keyword>
        <Keyword MajorTopicYN="Y">Contraceptive Implants</Keyword>
        <Keyword MajorTopicYN="N">Contraceptive Methods</Keyword>
        <Keyword MajorTopicYN="N">Developed Countries</Keyword>
        <Keyword MajorTopicYN="N">Family Planning</Keyword>
        <Keyword MajorTopicYN="N">Health</Keyword>
        <Keyword MajorTopicYN="Y">Iud</Keyword>
        <Keyword MajorTopicYN="Y">Iud, Copper Releasing</Keyword>
        <Keyword MajorTopicYN="Y">Iud, Hormone Releasing</Keyword>
        <Keyword MajorTopicYN="Y">Levonorgestrel</Keyword>
        <Keyword MajorTopicYN="Y">Literature Review</Keyword>
        <Keyword MajorTopicYN="N">North America</Keyword>
        <Keyword MajorTopicYN="N">North Carolina</Keyword>
        <Keyword MajorTopicYN="N">Northern America</Keyword>
        <Keyword MajorTopicYN="N">Public Health</Keyword>
        <Keyword MajorTopicYN="Y">Safety</Keyword>
        <Keyword MajorTopicYN="N">United States</Keyword>
      </KeywordList>
      <GeneralNote Owner="PIP">TJ: JOURNAL OF REPRODUCTIVE MEDICINE.</GeneralNote>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1999</Year>
          <Month>4</Month>
          <Day>15</Day>
          <Hour>2</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2000</Year>
          <Month>2</Month>
          <Day>19</Day>
          <Hour>9</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1999</Year>
          <Month>4</Month>
          <Day>15</Day>
          <Hour>2</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">10202746</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
